Company / Operating Income per Share
Wave Life Sciences Ltd. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.41
FY2025
5-year range
-$3.14 / -$0.78
FY2021-FY2025
Trend
-51.9%
vs FY2024
Sector context
#100 of 201
Health Care
What the data says
At $-1.41, Wave Life Sciences Ltd.'s operating income per share ranks #100 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-6.07 in FY2020 to $-0.78 in FY2023.
Based on SEC 10-K filings.
-1.41 in FY2025.
Declined from $-0.78 to $-1.41 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#100 of 201 in Health CareTop 50% of 201This company -$1.41 Sector average -$28.56
▼
+95.1% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 51.9% year-over-year.
- Ranks #100 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.41 | -51.9% |
| FY2024 | -$0.93 | -18.4% |
| FY2023 | -$0.78 | +63.1% |
| FY2022 | -$2.12 | +32.5% |
| FY2021 | -$3.14 | +48.2% |
| FY2020 | -$6.07 | -74.6% |
| FY2019 | -$3.47 | +39.4% |
| FY2018 | -$5.73 | -31.6% |
| FY2017 | -$4.36 | -68.5% |
| FY2016 | -$2.59 | -208.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026